AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 14th day of September, 2017, between Vericel Corporation, a Michigan corporation (the “Company”), and Michael Halpin (the “Executive”).
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances) • Massachusetts
This First Amendment to Executive Employment Agreement (this “Amendment”) is entered into and effective as of June 3, 2019, by and between Michael Halpin (“Executive”), and Vericel Corporation, a Michigan corporation (the “Company”).
SIXTH AMENDMENT TO DISTRIBUTION AGREEMENTDistribution Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances)
This Sixth Amendment to the Distribution Agreement ("Sixth Amendment") is between Vericel Corporation ("Vericel") and Orsini Pharmaceutical Services, Inc. (“Orsini"). This Sixth Amendment is effective as of April 18, 2019 ("Effective Date").
First Amendment to Dispensing AgreementDispensing Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances)
This First Amendment to the July 26, 2018 Dispensing Agreement (“Agreement”) between Vericel Corporation and AllCare Plus Pharmacy (“AllCare”) shall be effective as of May 1, 2019 (“Effective Date”).
SUPPLY AGREEMENT by and between MEDIWOUND LTD. and VERICEL CORPORATION May 6, 2019Supply Agreement • August 6th, 2019 • Vericel Corp • Biological products, (no disgnostic substances) • New York
THIS SUPPLY AGREEMENT (the “Agreement”) is entered into as of May 6, 2019 (the “Effective Date”), by and between Vericel Corporation, a corporation organized and existing under the laws of Michigan and having a principal place of business at 64 Sidney Street, Cambridge, MA 02139 (“Vericel”) and MediWound Ltd., a corporation organized and existing under the laws of Israel and having a principal place of business at 42 Hayarkon Street, Yavne, Israel 8122745 (“MediWound”). Vericel and MediWound may each be referred to herein individually as a “Party” and collectively as the “Parties.”
